Amarin Corporation PLC (NASDAQ: AMRN) is a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health. The company’s first FDA-approved product, Vascepa®, is a prescription medication that, when used alongside a low-fat and low-cholesterol diet, has been shown to lower high levels of triglycerides in adults without raising LDL Cholesterol […]
The Stocks To Buy Now Blog
Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.